These drugs may reduce inflammation and fibrosis in the kidneys and improve overall metabolic health, which in turn benefits kidney function
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
If you ever experience dizziness, shakes, or confusion (signs of low blood sugar) during exercise on a GLP-1 RA, treat it immediately (consume fast carbs) and consider adjusting your nutrition plan (and speak to your doctor )
Plus, the protein in eggs plays a vital role in maintaining muscle mass, which is especially important during weight loss
While direct evidence in the context of GLP-1RA remains limited, these approaches may enable identification of early molecular signatures of treatment response and stratify patients based on underlying plaque biology
Last week, Eli Lillys orforglipron has become the first oral, non-peptide GLP-1 receptor agonist to clear a Phase 3 trial, showing strong efficacy in reducing A1C (up to 1.6%) and body weight (up to 7.9%) in people with type 2 diabetes
